Session Information
-
WCLC 2018
19th World Conference on Lung Cancer
Conference Program for the 19th World Conference on Lung Cancer in Toronto, Canada
Download PDF of the Abstract Book: Click Here.
Presentation Date(s):- Sept 23 - 26, 2018
- Total Presentations: 2391
September 23 Sun
Sep 23 Monday
September 24 Mon
Sep 24 Tuesday
September 25 Tue
Sep 25 Wednesday
September 26 Wed
Sep 26
-
+
OA05 - Clinical Trials in IO
- 13:30 - 15:00
- 9/24/2018
- Location: Room 106
- Type: Oral Abstract Session
- Track: Advanced NSCLC
-
+
OA05.02 - Epacadostat Plus Pembrolizumab in Patients with Non-Small Cell Lung Cancer: Phase 1/2 Results from ECHO-202/KEYNOTE-037
13:40 - 13:50 | Presenter: Liza Villaruz | Author(s): Bryan J Schneider, Todd M. Bauer, Alexander Spira, Gina D'Amato, Jeffery Wasser, Ani Balmanoukian, Primo Lara, Anthony Olszanski, Thomas Gajewski, Sandip Patel, Ahmad Tarhini, Joshua Michael Bauml, Emmett Schmidt, Jill Bowman, Jeannie Daniel, Sherry Owens, Tara C Mitchell
- Abstract
Loading...
-
+
MA08 - Clinical Trials in Brain Metastases
- 15:15 - 16:45
- 9/24/2018
- Location: Room 203 BD
- Type: Mini Oral Abstract Session
- Track: Advanced NSCLC
-
+
MA08.05 - Brain Penetration of Lorlatinib and Cumulative Incidence Rates for CNS and Non CNS Progression from a Phase 1/2 Study
15:45 - 15:50 | Presenter: Todd M. Bauer | Author(s): Alice T. Shaw, Melissa L. Johnson, Alejandro Navarro, Justin F Gainor, Holger Thurm, Yazdi K. Pithavala, Antonello Abbattista, Enriqueta Felip
- Abstract
Loading...
-
+
P1.13 - Targeted Therapy (Not CME Accredited Session)
- 16:45 - 18:00
- 9/24/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P1.13-06 - First-Line Lorlatinib Versus Crizotinib for Advanced Anaplastic Lymphoma Kinase-Positive (ALK+) Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Alice T. Shaw | Author(s): Todd M. Bauer, Toshiaki Takahashi, Christina S Baik, Yasushi Goto, Anna Polli, Marina Carpentieri, Jean-François Martini, Ben J Solomon
- Abstract
Loading...
-
+
OA12 - Novel Therapies in MET, RET and BRAF
- 15:15 - 16:45
- 9/25/2018
- Location: Room 106
- Type: Oral Abstract Session
- Track: Targeted Therapy
-
+
OA12.07 - Clinical Activity of LOXO-292, a Highly Selective RET Inhibitor, in Patients with RET Fusion+ Non-Small Cell Lung Cancer
16:20 - 16:30 | Presenter: Geoffrey R. Oxnard | Author(s): Vivek Subbiah, Keunchil Park, Todd M. Bauer, Lori J Wirth, Vamsidhar Velcheti, Manisha Shah, Benjamin Besse, Valentina Boni, Karen L. Reckamp, Herbert H Loong, Lyudmila Bazhenova, Ben J Solomon, Daniel S.W. Tan, Jyoti Patel, Melissa L. Johnson, Anas Gazzah, Tony S. Mok, Steve Smith, Brian Tuch, Kevin Ebata, Edward Y Zhu, Michele M Nguyen, Xin Huang, Scott Cruickshank, S Michael Rothenberg, Alexander Drilon
- Abstract
Loading...